Topiramate is effective for status epilepticus and seizure control in neuraminidase deficiency;Topiramato é efetivo no tratamento de estado de mal epiléptico e controle de crises na deficiência de neuraminidase

Arquivos de Neuro-Psiquiatria

Volumn 69, Issue 3, 2011, Pages 565-566

  Bragatti, José Augusto ^a   Torres, Carolina Machado ^a   Netto, Cristina Brinckmann Oliveira ^a   Vedolin, Leonardo ^b   Garzon, Eliana ^c   de Mello Rieder, Carlos Roberto ^a   Schwartz, Ida Vanessa Doederlein ^a,d   Bianchin, Marino Muxfeldt ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b HOSPITAL MOINHOS DE VENTO   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBAZAM; GLYCOSIDASE; MIDAZOLAM; PRIMIDONE; SIALIDASE; TOPIRAMATE; VALPROIC ACID;

ADOLESCENT; BRAIN ATROPHY; CASE REPORT; DRUG DOSE INCREASE; DRUG EFFICACY; DYSOSTOSIS; EPILEPTIC STATE; FEMALE; HUMAN; LETTER; MYOCLONUS SEIZURE; NUCLEAR MAGNETIC RESONANCE IMAGING; SEIZURE; SHORT STATURE; SIALIDOSIS;

EID: 79960667357     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2011000400031     Document Type: Letter

References (5)

1. Bleck TP. Intensive care unit management of patients with status epilepticus. Epilepsia 2007;48(Suppl 8):S59-S60.
2. Costello DJ, Cole AJ. Treatment of acute seizures and status epilepticus. J Intensive Care Med 2007;22:319-347.
3. Gopaul KP, Crook MA. The inborn errors of sialic acid metabolism and their laboratory investigation. Clin Lab 2006;52:155-169.
4. Lowden JA, O'Brien JS. Sialidosis: a review of human neuraminidase deficiency. Am J Hum Genet 1979;31:1-18.
5. Pshezhetsky AV, Richard C, Michaud L, et al. Cloning expression and chromosomal mapping of lysossomal sialidase and characterization of mutations in sialidosis. Nat Genet 1997;15:316-320.